Follow
Steven Pavletic
Steven Pavletic
National Cancer Institute, NIH
Verified email at croampro.com - Homepage
Title
Cited by
Cited by
Year
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich, D Weisdorf, S Pavletic, G Socie, JR Wingard, SJ Lee, ...
Biology of blood and marrow transplantation 11 (12), 945-956, 2005
41272005
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working …
MH Jagasia, HT Greinix, M Arora, KM Williams, D Wolff, EW Cowen, ...
Biology of Blood and Marrow Transplantation 21 (3), 389-401. e1, 2015
25132015
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working …
MH Jagasia, HT Greinix, M Arora, KM Williams, D Wolff, EW Cowen, ...
Biology of Blood and Marrow Transplantation 21 (3), 389-401. e1, 2015
25132015
ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells
DW Lee, BD Santomasso, FL Locke, A Ghobadi, CJ Turtle, JN Brudno, ...
Biology of blood and marrow transplantation 25 (4), 625-638, 2019
22582019
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
M Jagasia, M Arora, MED Flowers, NJ Chao, PL McCarthy, CS Cutler, ...
Blood, The Journal of the American Society of Hematology 119 (1), 296-307, 2012
8002012
T cells genetically modified to express an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma
JN Brudno, I Maric, SD Hartman, JJ Rose, M Wang, N Lam, ...
Journal of Clinical Oncology 36 (22), 2267, 2018
7112018
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation
JN Kochenderfer, ME Dudley, RO Carpenter, SH Kassim, JJ Rose, ...
Blood, The Journal of the American Society of Hematology 122 (25), 4129-4139, 2013
7002013
Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell …
JN Brudno, RPT Somerville, V Shi, JJ Rose, DC Halverson, DH Fowler, ...
Journal of clinical oncology 34 (10), 1112, 2016
6532016
Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft …
HM Shulman, D Kleiner, SJ Lee, T Morton, SZ Pavletic, E Farmer, ...
Biology of Blood and Marrow Transplantation 12 (1), 31-47, 2006
5222006
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic …
SZ Pavletic, P Martin, SJ Lee, S Mitchell, D Jacobsohn, EW Cowen, ...
Biology of Blood and Marrow Transplantation 12 (3), 252-266, 2006
4582006
The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in …
KR Cooke, L Luznik, S Sarantopoulos, FT Hakim, M Jagasia, DH Fowler, ...
Biology of Blood and Marrow Transplantation 23 (2), 211-234, 2017
4362017
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research
S Arai, M Arora, T Wang, SR Spellman, W He, DR Couriel, ...
Biology of Blood and Marrow Transplantation 21 (2), 266-274, 2015
4252015
Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD …
J Pidala, B Kurland, X Chai, N Majhail, DJ Weisdorf, S Pavletic, C Cutler, ...
Blood, The Journal of the American Society of Hematology 117 (17), 4651-4657, 2011
3882011
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in …
D Couriel, PA Carpenter, C Cutler, J Bolaños-Meade, NS Treister, ...
Biology of Blood and Marrow Transplantation 12 (4), 375-396, 2006
3852006
Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic …
S O'Brien, JO Moore, TE Boyd, LM Larratt, A Skotnicki, B Koziner, ...
Journal of Clinical Oncology 25 (9), 1114-1120, 2007
3732007
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic …
SJ Lee, D Wolff, C Kitko, J Koreth, Y Inamoto, M Jagasia, J Pidala, ...
Biology of Blood and Marrow Transplantation 21 (6), 984-999, 2015
3652015
EBMT− NIH− CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
HM Schoemans, SJ Lee, JL Ferrara, D Wolff, JE Levine, KR Schultz, ...
Bone marrow transplantation 53 (11), 1401-1415, 2018
3402018
Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease
D Wolff, M Schleuning, S von Harsdorf, U Bacher, A Gerbitz, M Stadler, ...
Biology of Blood and Marrow Transplantation 17 (1), 1-17, 2011
3292011
Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD
D Wolff, A Gerbitz, F Ayuk, A Kiani, GC Hildebrandt, GB Vogelsang, ...
Biology of Blood and Marrow Transplantation 16 (12), 1611-1628, 2010
3102010
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis
RA Nash, JD Bowen, PA McSweeney, SZ Pavletic, KR Maravilla, M Park, ...
Blood 102 (7), 2364-2372, 2003
2872003
The system can't perform the operation now. Try again later.
Articles 1–20